期刊文献+

microRNA在非小细胞肺癌血清中的研究进展 被引量:8

下载PDF
导出
摘要 肺癌是世界范围内恶性肿瘤死亡的第一原因,其中80%是非小细胞肺癌(NSCLC),其5年生存率只有15%~20%。这主要取决于缺少早发现,早诊断的有效方法。因此寻找检测早期NSCLC的标志物是肿瘤界的重要的方向。MicroRNAs(miRNAs)是一种非编码蛋白质,涉及到基因表达调控的一组小RNA分子,其长度为20~24nt。
机构地区 解放军第
出处 《临床肺科杂志》 2013年第4期726-728,共3页 Journal of Clinical Pulmonary Medicine
  • 相关文献

参考文献18

  • 1Wang J,Chen J,Chang P,et al.MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease[J].Cancer Prev Res,2009,2(9):807. 被引量:1
  • 2Tsujiura M,Ichikawa D,Komatsu S,et al.Circulating microRNAs in plasma of patients with gastric cancers[J].Br J Cancer,2010,102(7):1174-79. 被引量:1
  • 3Zhang JG,Wang JJ,Zhao,et al.MicroRNA-21(miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC)[J].Clin chim Acta,2010,411(11-12):846-52. 被引量:1
  • 4Zhao-Xia,Hai-Bo Bian,Ji-RongWang,et al.Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer[J].Surg Oncol,2011,104(7):847-851. 被引量:1
  • 5Juan Wei Lian-ke Liu Wen Gao Cheng-jun Zhu Yi-qian Liu Ting Cheng Yong-qian Shu.Reduction of Plasma MicroRNA-21 is Associated with Chemotherapeutic Response in Patients with Non-small Cell Lung Cancer[J].Chinese Journal of Cancer Research,2011,23(2):123-128. 被引量:9
  • 6Meng Henson R,tang M,et al.Involvement of human micro-RNA in growth and response to chemotherapy in human cholangio carcinoma cell lines[J].Gastroenterology,2006,130(7):2113-29. 被引量:1
  • 7Si ML,Zhu S,Wu H,et aI.MiR-21-mediated tumor growth[J].Oncogene,2007,26(19):2799-803. 被引量:1
  • 8Bianchi F,Nicassio F,Marzi M,et al.A serum circulating microRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer[J].EMBO Molecular Medicine,2011,3(8):495-503. 被引量:1
  • 9Pei-Ying Lin,Pan-ChyrYang,Circulating miRNA signature for early diagnosis of lung cancer[J].EMBO Molecular Medicin,2011,3(8):436-437. 被引量:1
  • 10Wang J,Chen J,Chang P,et al.MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease[J].Cancer Prev Res,2009.2(9):807. 被引量:1

二级参考文献2

共引文献16

同被引文献101

  • 1周伟生,杨贤卫,何蓉.中晚期周围型肺癌临床分期病理分型与中医证型相关性研究[J].中医药学刊,2006,24(8):1436-1437. 被引量:29
  • 2徐振哗,杨宇飞.肺癌中西医综合治疗[M].北京:人民卫生出版社.2002:259,192. 被引量:16
  • 3元·朱震亨.丹溪心法[M].北京:人民卫生出版社,2005:78,79. 被引量:35
  • 4田代华,整理.黄帝内经素问[M].北京:人民卫生出版社,2006:20,138,22,17,126. 被引量:9
  • 5Wang R, Li N, Zhang Y, et al. Circulating microRNAs are promis- ing no,Jel biomarkers of acute myocardial iafarction [ J 1. Intern Med,201 1,50( 17 ) : 1789-1795. 被引量:1
  • 6Yang B, Lin H, Xiao J,et al. The muscle-specific microRNA miR-I regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2[ J]. Nat Med,2007,13(4) :486-491. 被引量:1
  • 7Li Q, Song X W, Zou J, et al. Attenuation of mlcroRNA-I dere- presses the cytoskeleton regulatory protein twinfifin-1 to provoke cardiac hypertrophy[J]. J Cell Sci ,2010,123 ( 14 ) :2444-2452. 被引量:1
  • 8Lu Y,Zhang Y, Shan H,et al. MicroRNA-1 downregulation by pro- pranolol in a rat model of myocardial infarction : a new mechanism for ischaemic eardioprotection [ J ]. Cardiovasc Res, 2009,84 ( 3 ) : 434-441. 被引量:1
  • 9Cheng Y,Tan N,Yang J, et al. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction [ J ]. Clin Sci ( Lond) ,2010,119(2):87-95. 被引量:1
  • 10Callis T E,Pandya K,Seok H Y ,et al. mieroRNA-208a is a regula- tor of cardiac hypertrophy and conduction in mice [ J ]. J Clin In- vest,2009,119 (9) : 2772-2786. 被引量:1

引证文献8

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部